REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 896.00
Bid: 893.00
Ask: 897.00
Change: 13.00 (1.47%)
Spread: 4.00 (0.448%)
Open: 890.00
High: 897.00
Low: 881.00
Prev. Close: 883.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Independent Non-Executive Director

18 Nov 2019 12:07

RNS Number : 7685T
JTC PLC
18 November 2019
 

18 November 2019

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Appointment of Independent Non-Executive Director

 

JTC, a global provider of fund, corporate and private wealth services to institutional and private clients, is pleased to announce the appointment of Erika Schraner as an Independent Non-Executive Director, joining the Board with immediate effect.

 

Erika brings to the Board a wealth of experience and expertise in professional services, with particular strength in the areas of commercial development, M&A and technology. A dual Swiss-US national, Erika obtained an MS & BA in Mathematics from EPFL Switzerland before going on to complete a PhD in Management Science & Engineering at Stanford University, USA. Erika began her post education executive career with IBM Corp in Silicon Valley and also worked for global cybersecurity leader Symantec Corp, now NortonLifeLock Inc. She then moved into senior professional services roles with Ernst & Young in Silicon Valley where as a Partner, she was the Americas Operational Transaction Services leader for the Technology sector. Most recently Erika was with PwC LLP in London, where until 2018 she was Partner, UK M&A Integration Leader & TMT M&A Advisory / Delivering Deal Value Leader.

 

Her board-level roles, held since 2001, have included serving as an Advisory Board Member for eBoomerang (USA) and Freeon Ltd (UK) and a Non-Executive Director of Kevian Capital Management LLP, a San Francisco based global asset management firm with US$200m in hedge fund assets and US$1bn in advisory assets. Erika currently holds one other Non-Executive Director role with Amino Technologies PLC (Cambridge, UK), whom she joined in 2019 and where she is also Chair of the Audit Committee and a member of the Nomination Committee.

Mike Liston, Non-Executive Chairman of JTC PLC, said:

 

"JTC's global growth strategy is all about the smart improvement of its traditional businesses combined with the equally smart acquisition and integration of new ones. Erika brings immediately relevant skills to the Board as the company pursues a range of opportunities in attractive growth markets."

 

Erika Schraner, added:

 

"I am excited to join the Board of JTC. With its dynamic and innovative approach to business, underpinned by its strong culture centred around its people and unique shared ownership model, JTC is well positioned for continued growth and success. I am delighted to have this opportunity to play a part in that."

 

There are no further details in respect of Erika Schraner requiring disclosure under Listing Rule 9.6.13.

 

For further information please contact:

 

Miranda Lansdowne

JTC (Jersey) Limited

Joint Company Secretary

+44 1534 700 000

Miranda.Lansdowne@jtcgroup.com

 

About JTC

 

JTC is a global provider of fund, corporate and private wealth services to institutional and private clients. The Company has a global presence, with over 700 staff operating from a network of 20 offices and assets under administration totalling c. US$ 110 billion.

 

JTC is committed to its shared ownership culture and philosophy, with management and staff holding over 20% of the equity in the firm, clearly aligning the interests of clients, employees and other stakeholders.

 

www.jtcgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABDBDBUGBBGCI
Date   Source Headline
30th Jun 20227:00 amRNSTotal Voting Rights
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:35 pmRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSIssue of Equity and Total Voting Rights
13th Jun 20224:00 pmRNSDirector's Share Dealing
13th Jun 20229:38 amRNSDirector's Share Dealing
1st Jun 20227:00 amRNSResult of AGM
5th May 202211:09 amRNSPDMR Shareholding
3rd May 20229:02 amRNSDirector's Other Appointments
28th Apr 20227:00 amRNSAnnual Financial Report and Notice of AGM
20th Apr 20227:00 amRNSVest and Grant of Conditional Share Awards
20th Apr 20227:00 amRNSDirector's Share Dealing
19th Apr 20227:00 amRNSFull Year Results
25th Mar 20227:00 amRNSAppointment of Independent Non-Executive Director
28th Feb 202210:00 amRNSPDMR Shareholding
22nd Feb 20228:59 amRNSDirector's Other Appointments
14th Feb 20229:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:00 amRNSPDMR Shareholding
4th Feb 202212:00 pmRNSNotification of Director's Share Dealing
3rd Feb 20227:00 amRNSPre-close Full Year Trading Update
1st Feb 202210:00 amRNSPDMR Shareholding
1st Feb 20229:24 amRNSHolding(s) in Company
28th Jan 202212:51 pmRNSPDMR and PCA Shareholding Notification
31st Dec 20219:33 amRNSDirector's Other Appointments
31st Dec 20217:00 amRNSTotal Voting Rights
22nd Dec 20217:00 amRNSDirector's Other Appointments
21st Dec 20219:26 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition of Essential Fund Services, LLC
2nd Dec 20217:00 amRNSCompletion of Acquisition and Issue of Equity
23rd Nov 20213:58 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSIssue of Equity
19th Nov 20217:00 amRNSAdmission of Shares
12th Nov 20212:56 pmRNSCompletion of Acquisition and Issue of Equity
26th Oct 20214:28 pmRNSHolding(s) in Company
11th Oct 20213:37 pmRNSHolding(s) in Company
8th Oct 20212:08 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSRESULTS OF PLACING
6th Oct 20215:02 pmRNSPROPOSED PLACING OF NEW ORDINARY SHARES
6th Oct 20214:59 pmRNSAcquisition of SALI
21st Sep 20217:01 amRNSInterim Results
21st Sep 20217:00 amRNSAcquisition of Ballybunion Capital Limited
17th Sep 20217:00 amRNSIssue of Equity
16th Sep 20217:00 amRNSAcquisition of Segue Partners
3rd Sep 20219:12 amRNSDirector's Other Appointments
23rd Aug 202110:00 amRNSDirector/PDMR Shareholding
19th Aug 20212:00 pmRNSNotification of Share Pledge by PDMR
11th Aug 20219:38 amRNSDirector's Other Appointments
28th Jul 202111:33 amRNSDirector Share Purchase
28th Jul 20219:33 amRNSDirector Share Purchase
22nd Jul 20217:00 amRNSGrant and Vesting of EIP Share Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.